Skip to NavigationSkip to content

brexit

Read the September edition of Pharmafocus online now!

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!

With a new Prime Minister, a renewed drive to vacate the European Union by the fixed date of 31 October by any means necessary, but a distinct lack of any tangible negotiation strategy – or indeed, any evidence of negotiations at all – the UK looks to be hurtling towards a no-deal Brexit.

Top Ten most popular articles on Pharmafile.com this week

It's Friday, meaning the weekend is within reach and it's time for a rundown of the most popular articles on Pharmafile.com over the past seven days:

10. Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

Though MPs are moving forward with their plan to block UK Prime Minister Boris Johnson’s supposed no-deal Brexit from the EU and the economic and medical harm that would cause, it has become known that Ireland will not succumb to the same medicine access issues that threaten too affect England.

Responding to Michael Gove, the Government’s Chancellor of the Duchy of Lancaster who has taken charge of planning for a no-deal exit, health officials said that two years of planning now mean that such an exit would not have an immediate impact on supply levels.

No-deal Brexit will "make the disintegration of the health service an ever more real prospect”, BMA warns

As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has warned of the “devastating impact” a no-deal Brexit would inflict on an already underfunded NHS over the challenging winter period.

The briefing paper, titled A health service on the brink: The dangers of a 'no deal' Brexit, details the wide-ranging damage such an exit would reap during a period when demand for the health service spikes each year.

British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal

The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that the UK will be leaving on the existing deal on 31 October 2019.

Those who think there will be a further delay to Brexit make up the biggest groups in America (41%) and Britain (38%), while 43% of Europeans believe the UK will leave with a no-deal Brexit.

In contrast just 24% of Americans and 16% of Britons think that a no-deal Brexit is the most likely option on 31 October 2019.

Britain call on companies to bid for 24 hour Brexit medicines shipping service contract

The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers carrying daily shipments of medicines into the UK after the Brexit deadline on 31 October.

The Department of Health and Social Care (DHSC) said the contract would form part of the UK’s contingency plans to deal with complications associated with Britain’s departure from the EU.

EU unprepared for no-deal Brexit, health experts warn

European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union.

Speaking to Reuters, Andy Powrie-Smith, an official at the European Federation of Pharmaceutical Industries and Associations, said: “Despite intensive preparation by industry for every scenario, a no-deal Brexit risks disruption to the supply of medicines” throughout the EU.

The comments come as Prime Minister Boris Johnson doubled down on the deadline of 31 October, as he suggested that Britain would leave whether it was with a deal or not.

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris Johnson voicing concerns over the nation’s ability to deliver cancer treatments to patients if the UK crashes out of the EU without a deal.

Representatives from the Royal College of Radiologists, the British Nuclear Medicine Society and the UK Radiopharmacy Group warned that a dry run of emergency medical supply deliveries

Royal Pharmaceutical Society in Scotland says contingency plans do not mitigate risk of no-deal Brexit

Image Credit: https://commons.wikimedia.org/wiki/File:Scottish_Parliament_building,_Holyrood.jpg

The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks of Brexit.

The RPS has warned that “several challenges remain” as they suggested that the Scottish and UK Government’s contingency plans do “not eliminate these risks.”

Speaking to Holyrood, Alex MacKinnon, the Director of the RPS in Scotland said: “We have sought to engage constructively with the UK Government on measures to mitigate the risks associated. However, several challenges remain.

Government to set up express freight service for medicines in case of no-deal Brexit

The Department of Health and Social Care (DHSC) plans to spend £3 million on emergency transport solutions for medicines in the case of a no-deal Brexit.

The Government has said it wants to hire an “express freight service” to transport medicines, blood and transplant tissue in the case of a no-deal Brexit.

“DHSC intends to run a procurement exercise to secure access to express parcel services between continental Europe and the United Kingdom (import and export), for the movement of parcel consignments of health care products,” the Government said.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches